Nuvalent (NUVL) Return on Capital Employed Growth (1y) (2022 - 2026)
Nuvalent (NUVL) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
31,429.00 |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
16,829.00 |
| 10 |
Nuvalent |
9.70 Bn |
9.70 Bn |
- |
-324.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-324.00 |
| Dec 31, 2025 |
-1,226.00 |
| Sep 30, 2025 |
-1,595.00 |
| Jun 30, 2025 |
-522.00 |
| Mar 31, 2025 |
-574.00 |
| Dec 31, 2024 |
210.00 |
| Sep 30, 2024 |
543.00 |
| Jun 30, 2024 |
-459.00 |
| Mar 31, 2024 |
-333.00 |
| Dec 31, 2023 |
-249.00 |
| Sep 30, 2023 |
-224.00 |
| Jun 30, 2023 |
-99.00 |
| Mar 31, 2023 |
-101.00 |
| Dec 31, 2022 |
-916.00 |
| Sep 30, 2022 |
-1,512.00 |
